NRG1 and Alzheimer disease: An underlying mechanistic question to this marker is whether alterations in NRG1 levels are related to a general process of synaptic degeneration and clearance or whether these changes occur as a response, positive or negative, to the development of AD pathology or to an increase in synaptic synthesis and release.